Index

Nolwenn Bühler (University of Lausanne, Switzerland and University of Neuchâtel, Switzerland)

When Reproduction Meets Ageing

ISBN: 978-1-83909-747-8, eISBN: 978-1-83909-746-1

Publication date: 27 May 2021

This content is currently only available as a PDF

Citation

Bühler, N. (2021), "Index", When Reproduction Meets Ageing (Emerald Studies in Reproduction, Culture and Society), Emerald Publishing Limited, Bingley, pp. 233-237. https://doi.org/10.1108/978-1-83909-746-120211002

Publisher

:

Emerald Publishing Limited

Copyright © 2021 Nolwenn Bühler. Published under exclusive license by Emerald Publishing Limited


INDEX

Accessory factor
, 82–83

Ageing
, 3, 98–99

biomedicalisation
, 12–13

biotechnologies and transformations
, 37–40

external signs
, 185

fecundity
, 61–62

fertility
, 61–62

ineluctability
, 39

infertile
, 14

irreversibility
, 39

localisation
, 91–92

mitochondria
, 94–95

nature
, 21–22

oocytes
, 141

ovaries
, 78–84

physical signs
, 185–186

population
, 55–57

predictor
, 69–70

reproductive
, 6–7, 15, 19, 186

simple matter
, 95–98

symptoms
, 4

women
, 185–186

Age limits, changing nature of
, 155–156

Age-related fertility
, 51–52

decline
, 63

fixity
, 196

materiality
, 36–37

ontological choreography
, 64

programmed nature
, 21

statistical choreographies
, 76–77

Age-related infertility
, 3, 144

assisted reproductive technologies (ARTs)
, 7

asymmetry
, 186

biologisation
, 93, 188

biology
, 5–6

biomedicalisation
, 18

overcoming
, 8

reproduction
, 17–18

in vitro fertilisation (IVF)
, 70–73

Age-related infertility decline
, 122–124

hormonal fluctuations of
, 122–124

Aging
, 148–152

biologisation
, 126–127

chronological age
, 115–117

fertility charts
, 119–120

follicles
, 121–122

follicle stimulating hormone (FSH)
, 111

hormonal stimulation
, 121–122

hormones
, 112–113

infertility decline, hormonal fluctuations of
, 122–124

natural cycles
, 121–122

ovaries
, 108–114

physical indicators
, 119–120

reproductive potential
, 103–108

resisting force
, 117–119

statistical age, uncertainties of
, 124–125

in vitro fertilisation (IVF)
, 101–102

Ambivalent anti-ageing dimension
, 131

American College of Obstetricians and Gynaecologists (ACOG)
, 54–55

American Society for Reproductive Medicine (ASRM)
, 54–55

Anti-ageing medicine
, 77

Anti-ageing promise
, 179–182

Anti-ageing technologies
, 5

Anticipatory socio-naturalization
, 120

Anti-depressants
, 16

Anti-essentialism
, 33–34

Anti-naturalisation
, 29–30, 33–34

Assisted reproductive technologies (ARTs)
, 4–8, 77, 101

development
, 38

egg donation
, 9–10

extending fertility
, 12

non-natural
, 12

science and medicine
, 189–190

statistical choreographies
, 51

Assumed choice
, 137

Augment
, 189

Biological clock
, 2, 9, 36–37, 51–52, 186

Biological control
, 37–38

Biological process
, 76–77

Biological quality
, 84

Biological reality
, 60

Biologisation
, 16, 126–127, 190, 192

Biology
, 34–36

Biomarkers
, 107

Biomedicalisation
, 7, 13, 187–189

Biomedicine
, 36–37

anti-ageing
, 6–7

reproductive
, 3, 10, 52

Biotechnologies
, 51–52

Birth defects
, 82

Blackboxed reality
, 102–103

Bodies
, 32–34

Cell death
, 162–164

Cell ontologies
, 170–177

common-sense
, 170–174

counting
, 174–176

oocyte
, 176–177

scientific and historical evidence conflate
, 170–174

Childbearing age
, 56–57

Chronic ageing
, 82–83

Chronological age
, 115–117

Chronomarkers
, 76–77

Comforting
, 2

Common-sense
, 170–174

Contraception
, 5–6

Controlled fertility
, 58

CoQ10
, 96

Counting
, 174–176

follicles
, 111

Critical age
, 67

Defective oocytes
, 81–83

Demography
, 55–56, 61

Developed populations
, 58

Discordant counts
, 164–166

Diversity
, 25

DNA
, 40, 93

Dogma
, 162–166

cell death
, 162–164

discordant counts
, 164–166

measured enthusiasm
, 167–170

neo-oogenesis
, 166–170

scepticism
, 167–170

Down’s syndrome
, 81–83, 93

Egg donation
, 8–10, 14, 84, 94, 99

aging
, 148–152

ambivalent anti-ageing dimension
, 131

anti-ageing technology
, 129–130

fertility
, 132–136

legitimisation nature
, 145–148

postmenopausal pregnancies
, 130

reproductive tourism
, 131

scientific choreographies
, 131

turning to
, 140–145

Egg freezing
, 9–11, 188

Egg-making stem cells
, 157

Egg precursor cells (EggPCSM)
, 161

Egg transfer
, 91

Egg vitrification
, 8

Energetic metabolism
, 96

Epigenetics
, 42

Essentialisation
, 26–27

Ethnocentrism
, 24

Facebook
, 10–11

Facing age-related fertility decline
, 142–143

Fecundity
, 57, 67

Feminist issue
, 34–36

Fertility. See also Age-related fertility
, 1

age alone
, 52–53

assisted reproductive technologies (ARTs)
, 52

biology
, 13–14

biomedicalisation
, 187

decline
, 53, 57, 76

delaying
, 2–3

developed
, 58

evolution
, 186

limits of
, 132–136

natural
, 53, 57–58

treatments
, 88

women’s age
, 63–65

Fertility charts
, 119–120

Fertility declining
, 106, 108

Fixity
, 193–198

Follicles
, 121–122

Follicle stimulating hormone (FSH)
, 111

Frozen sperm
, 64–65

Gender
, 23, 186

biological/social
, 6–7

implications
, 51–52

nature-cultures
, 25–50

social
, 28–32

Genetic programming
, 21

Germline stem cells (GSCs)
, 158–159

Google Scholar
, 81

Historical population
, 57, 60, 63

Homeostasis
, 96

Homogenisation
, 27

Hormonal fluctuations
, 122–124

Hormonal stimulation
, 121–122

Human exceptionalism
, 24

Human Genome Project (HGP)
, 37–38, 40

Human ovaries
, 79–81

Hutterites
, 58–60

Ineluctability
, 39

Infertility
, 5–6

Intracytoplasmic sperm injection (ICSI)
, 117–118

In vitro fertilisation (IVF)
, 2–3, 8, 37–38, 51–52, 101–102

age-related infertility
, 70–73

cycles
, 75–76

egg donation
, 8

limits
, 195

oocytes
, 85–86

statistics
, 68–69

test-tube baby
, 63

In vivo model
, 65, 69, 84, 94

Irreversibility
, 39

Late pregnancy
, 132

Legitimisation
, 145–148

Liberating potential
, 28–32

Malthusian matrix
, 57

Masculinity
, 29

Material feminism
, 17, 47

Materialism
, 17, 47

Materialist feminism
, 29–30

Materiality
, 36–37

Medical emergency
, 109–110

Medicalisation
, 7

Medically assisted extension of fertility
, 154–155

Meiosis
, 83–84

Menstrual cycles
, 120

Milk bottle universe
, 58–60

Miscarriages
, 61–62

Mitochondrial DNA
, 94–95

Mongolian imbeciles
, 82, 93

Motivation
, 151

Multiple realities
, 43–46

Natural cycles
, 121–122

Natural fertility
, 53, 57–58

Naturalisation
, 16, 25, 27

Nature-cultures
, 23–25

gender
, 25–50

sex
, 25–50

Neo-oogenesis
, 166–170

Non-contraceptive populations
, 57

Obstacle course
, 148

Old eggs
, 76–77, 99

Ontological choreographies
, 43, 46, 64

Oocytes
, 76, 79, 176–177

defective
, 81–83

maturation
, 90

quality
, 92

uterus and
, 90

Oogonial stem cells (OSC)
, 158

Ooplasmic transfer
, 94–99

Optimists
, 178–179

Ovarian ageing
, 76–77, 81, 91–92

Ovarian capital
, 80

Ovarian reserve
, 76–77

Ovaries
, 108–114

Ovary stem cells
, 157

Ovular dysgenesis
, 81–82

Personal emergency
, 109–110

Pessimists
, 178–179

Physiological age
, 75–76

Plastic biologies
, 40–43

Plasticity
, 193–198

Population
, 51–52

age
, 55–57

fertility
, 55–57

historical
, 57, 60, 63

non-contraceptive
, 57

primitive
, 58

Posteriori narrative
, 139

Postmenopausal mother
, 5

Preimplantation genetic diagnostic (PGD)
, 8

Primitive populations
, 58

Production line hypothesis
, 82

Progressive and irreversible process
, 97

Promissory work
, 177–184

anti-ageing promise
, 179–182

optimists
, 178–179

pessimists
, 178–179

separating from reality
, 182–184

Psychoanalysis
, 30

Psychological dimension
, 151

PubMed
, 81

Quality of life
, 84

Racial theory of fecundity
, 57

Racism
, 24

Regeneration

cell death
, 162–164

Dogma
, 162–166

egg precursor cells (EggPCSM)
, 161

germline stem cells (GSCs)
, 158–159

oogonial stem cells (OSCs)
, 158

ovary stem cells
, 157

Rejuvenating effects
, 4, 94, 99

Reproduction
, 3, 21

ageing
, 4, 15, 19, 83

biotechnologies and transformations
, 37–40

embryo development
, 90

fertilisation
, 90

implantation
, 90

locating age
, 77–78

oocyte maturation
, 90

population
, 56

rejuvenation and
, 4

sexual
, 56

social studies
, 13–15

Reproductive ageing
, 81, 85, 150, 186, 188–189

Reproductive medicine
, 54, 62–63

Reproductive Medicine Act (RMA)
, 9–10

Reproductive potentials
, 103–108

Reproductive tourism
, 135–136

Resisting force
, 117–119

Reversing childbirth postponement
, 51–52

Risk category
, 39

RNA
, 83

Scepticism
, 167–170

Science and technology studies (STS)
, 5, 17, 21–22

biomedical
, 37–38

feminist
, 34–36, 41

Sexism
, 24

vs. gender
, 185

nature-cultures
, 25–50

versions
, 35

Sexual intercourse
, 120

Social constructivism
, 25, 27

Social essentialism
, 33–34

Social norms
, 34

Sperm donation
, 9–10, 62–63

Statistical age, uncertainties of
, 124–125

Stem cells
, 77

Strategic naturalisation processes
, 147

Swiss Federation of Physicians (FMH)
, 134

Swiss Society for Reproductive Medicine (SSRM)
, 134

Technological fix
, 148

Test-tube baby
, 63

Tissue transplantation
, 86

Toxicants
, 16

Toxic damage
, 82–83

Uterus
, 86–92

Viagra
, 39

Web of Science
, 81

Women’s age, fertility
, 63–65

Yahoo
, 10–11